| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |